CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 6.37: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.32%Below 5Y avg (0.80%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
26.7%Sustainable
Last Ex-Dividend
Jun 25, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
3.75BCNY559.58M · vs all stocks (USD)
Trailing P/E
82.24xRevenue (TTM)
726.62MCNY108.43M · vs all stocks (USD)
Profit Margin
6.19%Beta
0.0710xvs all stocks
52-Week Change
-47.41%vs all stocks
Market Capitalization
3.75BCNY559.58M · vs all stocks (USD)
Enterprise Value
4.05BCNY604.59M · vs all stocks (USD)
Trailing P/E
82.24xForward P/E
29.48xPrice to Sales (TTM)
5.16xPrice to Book (MRQ)
3.49xEnterprise to Revenue
5.58xEnterprise to EBITDA
24.66xGross Margin
68.68%Profit Margin
6.19%Operating Margin
13.25%Return on Assets (TTM)
3.89%Return on Equity (TTM)
4.11%Revenue (TTM)
726.62MCNY108.43M · vs all stocks (USD)
Revenue per Share (TTM)
6.05CNYUpdated Sep 20, 2026Quarterly Revenue Growth
22.80%Gross Profit (TTM)
550.29MCNY82.11M · vs all stocks (USD)
EBITDA (TTM)
106.12MCNY15.84M · vs all stocks (USD)
Net Income (TTM)
44.97MCNY6.71M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.10%Operating Cash Flow (TTM)
11.57MCNY1.73M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
19.11MCNY2.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.32%vs all stocks
5-Year Average Dividend Yield
0.80%vs all stocks
Payout Ratio
26.69%Minority Interest (Equity)
46.56MCNYFY2025 · Dec 31, 2025Revenue
671.05MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
117.35MCNYFY2025 · Dec 31, 2025Gross Profit
553.69MCNYFY2025 · Dec 31, 2025Operating Income
89.73MCNY13.39M · vs all stocks (USD)
Pre-tax Income
47.30MCNYFY2025 · Dec 31, 2025Income Tax Expense
6.57MCNYFY2025 · Dec 31, 2025Net Income
40.73MCNYFY2025 · Dec 31, 2025EBIT
53.96MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
151.62MCNYFY2025 · Dec 31, 2025Research & Development
40.46MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
336.16MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.44MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
59.12KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3505CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3505CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
120.00MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
120.00MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
40.73MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.33MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-35.54MCNYFY2025 · Dec 31, 2025Free Cash Flow
-68.68MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
66.19MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
40.73MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.64MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-70.77MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-12.14MCNYFY2025 · Dec 31, 2025Capital Expenditures
-33.14MCNYFY2025 · Dec 31, 2025Purchase of Investments
-9.10MCNYFY2025 · Dec 31, 2025Sale of Investments
1.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-41.24MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
234.30MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-222.10MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-19.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-9.13MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-16.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
120.00MSharesUpdated Sep 20, 2026Float Shares
52.42MSharesUpdated Sep 20, 2026% Held by Insiders
56.21%vs all stocks
% Held by Institutions
2.29%vs all stocks
Total Cash (MRQ)
22.88MCNY3.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1910CNYUpdated Sep 20, 2026Total Debt (MRQ)
277.16MCNY41.36M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2473xCurrent Ratio (MRQ)
1.19xBook Value per Share (MRQ)
8.95CNYUpdated Sep 20, 2026Total Assets
1.53BCNY228.62M · vs all stocks (USD)
Total Current Assets
384.32MCNYFY2025 · Dec 31, 2025Total Liabilities
432.26MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.15BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
63.32MCNYFY2025 · Dec 31, 2025Total Current Liabilities
368.94MCNYFY2025 · Dec 31, 2025Cash
66.19MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
66.19MCNYFY2025 · Dec 31, 2025Accounts Receivable
190.44MCNYFY2025 · Dec 31, 2025Inventory
76.58MCNYFY2025 · Dec 31, 2025Accounts Payable
62.28MCNYFY2025 · Dec 31, 2025Short-term Debt
232.99MCNYFY2025 · Dec 31, 2025Other Current Liabilities
19.34MCNYFY2025 · Dec 31, 2025Long-term Debt
53.74MCNYFY2025 · Dec 31, 2025Common Stock (Book)
120.00MCNYFY2025 · Dec 31, 2025Retained Earnings
660.77MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.10BCNY164.12M · vs all stocks (USD)
52-Week Low
27.68CNYUpdated Sep 20, 202652-Week High
73.40CNYUpdated Sep 20, 202652-Week Change
-47.41%vs all stocks
Beta
0.0710xvs all stocks
50-Day MA
32.45CNYUpdated Sep 20, 2026200-Day MA
40.38CNYUpdated Sep 20, 2026Avg 10-Day Volume
2.03MSharesUpdated Sep 20, 2026Avg 30-Day Volume
3.47MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.3800CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 6,709,772.204Operating Cash Flow (USD, TTM): 1,726,968.871
High gross margins eroded by operating costsNotable
Gross Margin: 0.69Profit Margin: 0.06
Financial Health
Altman Z-Score 6.37: safe zoneNotable
Altman Z-Score: 6.37
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Gujarat Themis Biosyn Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Transtek Medical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Well Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Neurogene Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Starry Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai General Healthy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Allogene Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Orient Gene Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow